General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Share overview

Novartis ordinary shares

ISIN CH0012005267
Bloomberg symbol NOVN VX
Reuters NOVN.VX
Currency CHF
Par value .5
Primary exchange SIX SWISS EXCHANGE
Index listings SMI, FTSE EUROTOP 100, SPI, SPI MID & LG CO., SPI LG CO., BLOOMBERG EUROPE 500, BE500 PHARMACEUTICALS, DJ STOXX 50 € PR, DJ STOXX 600 € P, DJ STOXX HEALTH CARE € P

Novartis ADR

ISIN US66987V1098
Bloomberg symbol NVS US
Reuters NVS.N
Currency USD
Par value
Primary exchange NEW YORK
Index listings NYSE COMPOSITE I, NYSE ARCA PHARMA, NYSE ARCA TECH 1, NYSE ARCA INT'L, WINS-SALEM JOURN, BLOOMBERG JRNL N, AMEX MKT 2000 HO, AMEX EUR 2001 HO, PHLX DRUG INDEX, BBG NEW JERSEY I
Stock chart